Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting

被引:0
作者
Nadler, E. [1 ]
Pavilack, M. [2 ]
Clark, J. [3 ]
Espirito, J. [3 ]
Fernandes, A. [2 ]
机构
[1] Texas Oncol Baylor Charles A Sammons Canc Ctr, US Oncol Hlth Informat & Internet Technol, Dallas, TX USA
[2] Astrazeneca, Hlth Econ & Outcomes Res, Gaithersburg, MD USA
[3] Mckesson Life Sci, Outcomes Res, The Woodlands, TX USA
关键词
NSCLC; EGFR; treatment patterns;
D O I
10.1016/j.jtho.2019.08.1262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.16-36
引用
收藏
页码:S601 / S601
页数:1
相关论文
共 50 条
[21]   Characteristics, treatment patterns, and survival among ALK plus non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study [J].
Cadranel, Jacques ;
Park, Keunchil ;
Arrieta, Oscar ;
Pless, Miklos ;
Bendaly, Edmond ;
Patel, Dony ;
Sasane, Medha ;
Nosal, Adam ;
Swallow, Elyse ;
Galebach, Philip ;
Kageleiry, Andrew ;
Stein, Karen ;
Degun, Ravi ;
Zhang, Jie .
LUNG CANCER, 2016, 98 :9-14
[22]   Study of patient characteristics, treatment patterns, EGFR testing patterns and outcomes in real-world patients with EGFRm+ non-small cell lung cancer [J].
Winfree, Katherine B. ;
Sheffield, Kristin M. ;
Cui, Zhanglin Lin ;
Sugihara, Tomoko ;
Feliciano, Josephine .
CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (01) :91-99
[23]   A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US [J].
Villalobos, Victor M. ;
Byfield, Stacey DaCosta ;
Ghate, Sameer R. ;
Adejoro, Oluwakayode .
CLINICAL SARCOMA RESEARCH, 2017, 7
[24]   Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China [J].
Wang, Y. ;
Lin, H. M. ;
Ning, N. ;
Du, F. ;
Gao, X. ;
Dong, Q. ;
Yang, G. ;
Xu, H. ;
He, Y. ;
Zhou, C. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S609-S609
[25]   An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices [J].
Ma, Esprit ;
Bonthapally, Vijayveer ;
Chawla, Anita ;
Lefebvre, Patrick ;
Swords, Ronan ;
Lafeuille, Marie-Helene ;
Fortier, Jonathan ;
Emond, Bruno ;
Duh, Mei Sheng ;
Dezube, Bruce J. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (11) :625-636
[26]   Treatment patterns and costs among US patients with diffuse large B-cell lymphoma not treated with 2L stem cell transplantation [J].
Acheampong, Teofilia ;
Gu, Tao ;
Le, Trong Kim ;
Keating, Scott J. .
FUTURE ONCOLOGY, 2024, 20 (10) :623-634
[27]   Diagnosis and Treatment of EGFR Mutated NSCLC among Arabic Patients [J].
Moskovitz, Mor ;
Wollner, Mira ;
Abu-Amna, Mahmoud ;
Agbaria, Abed .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S506-S507
[28]   Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset [J].
Cho, Byoung Chul ;
Chewaskulyong, Busayamas ;
Lee, Ki Hyeong ;
Dechaphunkul, Arunee ;
Sriuranpong, Virote ;
Imamura, Fumio ;
Nogami, Naoyuki ;
Kurata, Takayasu ;
Okamoto, Isamu ;
Zhou, Caicun ;
Cheng, Ying ;
Cho, Eun Kyung ;
Voon, Pei Jye ;
Lee, Jong-Seok ;
Mann, Helen ;
Saggese, Matilde ;
Reungwetwattana, Thanyanan ;
Ramalingam, Suresh S. ;
Ohe, Yuichiro .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (01) :99-106
[29]   Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2) [J].
Janne, P. ;
Planchard, D. ;
Cheng, Y. ;
Yang, J. C. -H. ;
Yanagitani, N. ;
Kim, S. -W. ;
Sugawara, S. ;
Yu, Y. ;
Fan, Y. ;
Geater, S. L. ;
Laktionov, K. ;
Lee, C. K. ;
Valdivieso, N. ;
Ahmed, S. ;
Maurel, J. -M. ;
Andrasina, I. ;
Goldman, J. ;
Ghiorghiu, D. ;
Kulkarni, D. ;
Huang, X. ;
Kobayashi, K. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S36-S37
[30]   Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US [J].
Michael Hull ;
Vamshi Ruthwik Anupindi ;
Mitchell DeKoven ;
Jing He ;
Jonathan Bouchard .
Advances in Therapy, 2023, 40 :3986-4003